Overview
Dr. Pranav Nair focuses on the management of gastrointestinal, genitourinary, haematological, and musculoskeletal malignancies, with a particular emphasis on rectal cancer. His clinical practice is centred on precision radiotherapy, including stereotactic radiotherapy (SRS/SBRT), image-guided radiotherapy (IGRT), and particle therapy. He is actively involved in clinical research, with multiple peer-reviewed publications and presentations at national and international conferences.
Areas of Expertise
- Gastrointestinal malignancies * Genitourinary malignancies
- Haematological malignancies [Transplant-conditioning radiotherapy (TBI/TMLI)]
- Musculoskeletal malignancies
- Stereotactic radiotherapy (SRS/SBRT)
- Precision radiotherapy, including image-guided techniques (IGRT)
- Advanced radiotherapy modalities, including particle therapy
Qualifications
Advanced Training in Particle Therapy
Heidelberg Institute for Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Baden-Württemberg, Germany
MD in Radiation Oncology
Amrita School of Medicine, Amrita Vishwa Vidyapeetham, Kochi
Compulsory Rotatory Residential Internship (CRRI)
Amrita School of Medicine, Amrita Vishwa Vidyapeetham, Kochi
Bachelor of Medicine and Bachelor of Surgery (MBBS)
Amrita School of Medicine, Amrita Vishwa Vidyapeetham, Kochi
Languages Known
- English
- Malayalam
- Hindi
Work Experience
Working at the department of Radiation Oncology, since March 2025.
Awards and Recognitions
- Special Award, Oral Presentation, Young Radiation Oncologists Conference 2025, Madurai, Tamil Nadu, India.
- Best Oral Presentation Award, Oncology 2024, Kochi, Kerala, India.
Indian Council of Medical Research (ICMR) Short Term Studentship, 2017: 'Time to positivity as a clinical predictor of bloodstream infections of Staphylococcus aureus'
Memberships:
- Association of Radiation Oncologists of India (AROI)
- European Society for Radiotherapy and Oncology (ESTRO)
- American Society for Radiation Oncology (ASTRO)
- European Society of Medical Oncology (ESMO)
- American Society of Clinical Oncology (ASCO)




